Comments
FDA advisers rebuff Regeneron gout drug
09.05.2012. | WASHINGTON (Reuters) - U.S. drug advisers unanimously voted against Regeneron Pharmaceuticals Inc's experimental drug to prevent gout flares, based on studies that tested the drug for only 16 weeks....
